Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Evidence against implant-derived cobalt toxicity: case report and retrospective study of serum cobalt concentrations in an orthopedic implant population.

Tolan NV, Sierra RJ, Moyer TP.

Clin Biochem. 2015 Feb;48(3):130-4. doi: 10.1016/j.clinbiochem.2014.10.012. Epub 2014 Nov 8.

PMID:
25445231
2.

Stone composition as a function of age and sex.

Lieske JC, Rule AD, Krambeck AE, Williams JC, Bergstralh EJ, Mehta RA, Moyer TP.

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2141-6. doi: 10.2215/CJN.05660614. Epub 2014 Oct 2.

3.

Cobalt and chromium measurement in patients with metal hip prostheses.

Estey MP, Diamandis EP, Van Der Straeten C, Tower SS, Hart AJ, Moyer TP.

Clin Chem. 2013 Jun;59(6):880-6. doi: 10.1373/clinchem.2012.193037. Epub 2012 Oct 31. No abstract available.

4.

Thiamine deficiency in Cambodian infants with and without beriberi.

Coats D, Shelton-Dodge K, Ou K, Khun V, Seab S, Sok K, Prou C, Tortorelli S, Moyer TP, Cooper LE, Begley TP, Enders F, Fischer PR, Topazian M.

J Pediatr. 2012 Nov;161(5):843-7. doi: 10.1016/j.jpeds.2012.05.006. Epub 2012 Jun 14.

5.

An unusual foreign body in the urinary bladder mimicking a parasitic worm.

Schmitt BH, Feder MT, Rokke DL, Moyer TP, Pritt BS.

J Clin Microbiol. 2012 Jul;50(7):2520-2. doi: 10.1128/JCM.00532-12. Epub 2012 Apr 25.

6.

Hereditary hemochromatosis: laboratory evaluation.

Moyer TP, Highsmith WE, Smyrk TC, Gross JB Jr.

Clin Chim Acta. 2011 Aug 17;412(17-18):1485-92. doi: 10.1016/j.cca.2011.04.007. Epub 2011 Apr 13. Review.

PMID:
21510925
7.

Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.

Wermers RA, Cooper K, Razonable RR, Deziel PJ, Whitford GM, Kremers WK, Moyer TP.

Clin Infect Dis. 2011 Mar 1;52(5):604-11. doi: 10.1093/cid/ciq188. Epub 2011 Jan 16.

PMID:
21239842
8.

Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine.

McAlpine DE, Biernacka JM, Mrazek DA, O'Kane DJ, Stevens SR, Langman LJ, Courson VL, Bhagia J, Moyer TP.

Ther Drug Monit. 2011 Feb;33(1):14-20. doi: 10.1097/FTD.0b013e3181fcf94d.

PMID:
21099743
9.

Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis.

Christensen KN, Lee CU, Hanley MM, Leung N, Moyer TP, Pittelkow MR.

J Am Acad Dermatol. 2011 Jan;64(1):91-6. doi: 10.1016/j.jaad.2009.12.044. Epub 2010 Oct 30.

PMID:
21036418
10.

Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

Epstein RS, Moyer TP, Aubert RE, O Kane DJ, Xia F, Verbrugge RR, Gage BF, Teagarden JR.

J Am Coll Cardiol. 2010 Jun 22;55(25):2804-12. doi: 10.1016/j.jacc.2010.03.009. Epub 2010 Apr 8.

11.

Warfarin sensitivity genotyping: a review of the literature and summary of patient experience.

Moyer TP, O'Kane DJ, Baudhuin LM, Wiley CL, Fortini A, Fisher PK, Dupras DM, Chaudhry R, Thapa P, Zinsmeister AR, Heit JA.

Mayo Clin Proc. 2009 Dec;84(12):1079-94. doi: 10.4065/mcp.2009.0278. Review.

12.

The future of laboratory testing moves toward pharmacogenomics.

Moyer TP, Yeo J.

MLO Med Lab Obs. 2009 Jul;41(7):30, 32, 34. No abstract available.

PMID:
19685694
13.

Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis.

Leung N, Pittelkow MR, Lee CU, Good JA, Hanley MM, Moyer TP.

NDT Plus. 2009 Aug;2(4):309-11. doi: 10.1093/ndtplus/sfp042. Epub 2009 Apr 23.

14.

Autonomic cardiovascular control during a novel pharmacologic alternative to ganglionic blockade.

Wilkins BW, Hesse C, Charkoudian N, Nicholson WT, Sviggum HP, Moyer TP, Joyner MJ, Eisenach JH.

Clin Pharmacol Ther. 2008 May;83(5):692-701. Epub 2007 Aug 8.

PMID:
17687267
15.

Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.

Ebbert JO, Dale LC, Patten CA, Croghan IT, Schroeder DR, Moyer TP, Hurt RD.

Nicotine Tob Res. 2007 Jan;9(1):43-52.

PMID:
17365735
16.

Nicotine percentage replacement among smokeless tobacco users with nicotine patch.

Ebbert JO, Post JA, Moyer TP, Dale LC, Schroeder DR, Hurt RD.

Drug Alcohol Depend. 2007 Jul 10;89(2-3):223-6. Epub 2007 Feb 14.

17.

Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents.

Wilkins BW, Hesse C, Sviggum HP, Nicholson WT, Moyer TP, Joyner MJ, Eisenach JH.

Clin Auton Res. 2007 Apr;17(2):77-84. Epub 2006 Dec 11.

PMID:
17160588
18.

Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing.

Woodworth A, Saunders AN, Koenig JW, Moyer TP, Turk J, Dietzen DJ.

Clin Chem. 2006 Apr;52(4):743-6. Epub 2006 Feb 2.

19.

Iqmik: a form of smokeless tobacco used among Alaska natives.

Renner CC, Enoch C, Patten CA, Ebbert JO, Hurt RD, Moyer TP, Provost EM.

Am J Health Behav. 2005 Nov-Dec;29(6):588-94.

PMID:
16336113
20.

Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates.

Hurt RD, Renner CC, Patten CA, Ebbert JO, Offord KP, Schroeder DR, Enoch CC, Gill L, Angstman SE, Moyer TP.

J Matern Fetal Neonatal Med. 2005 Apr;17(4):281-9.

PMID:
16147838
21.

Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis.

Butensky E, Fischer R, Hudes M, Schumacher L, Williams R, Moyer TP, Vichinsky E, Harmatz P.

Am J Clin Pathol. 2005 Jan;123(1):146-52.

PMID:
15762291
22.

Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users.

Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD.

Addict Behav. 2004 Feb;29(2):349-55.

PMID:
14732423
23.

National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department.

Wu AH, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, Otten EM, Welch SL, Wax P; National Academy of Clinical Biochemistry Laboratory Medicine.

Clin Chem. 2003 Mar;49(3):357-79.

24.

Pharmacogenomics and reducing the frequency of adverse drug events.

O'Kane DJ, Weinshilboum RM, Moyer TP.

Pharmacogenomics. 2003 Jan;4(1):1-4. No abstract available.

25.

Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes.

Schroeder DR, Ogburn PL Jr, Hurt RD, Croghan IT, Ramin KD, Offord KP, Moyer TP.

J Matern Fetal Neonatal Med. 2002 Feb;11(2):100-7.

PMID:
12375538
26.
27.

Performance characteristics of four free phenytoin immunoassays.

Roberts WL, Annesley TM, De BK, Moulton L, Juenke JM, Moyer TP.

Ther Drug Monit. 2001 Apr;23(2):148-54.

PMID:
11294515
28.

Carbidopa/levodopa for smoking cessation: a pilot study with negative results.

Hurt RD, Ahlskog JE, Croghan GA, Offord KP, Wolter TD, Croghan IT, Moyer TP.

Nicotine Tob Res. 2000 Feb;2(1):71-8.

PMID:
11072443
29.

Effects of transdermal nicotine treatment on structure and function of coronary artery bypass grafts.

Clouse WD, Yamaguchi H, Phillips MR, Hurt RD, Fitzpatrick LA, Moyer TP, Rowland C, Schaff HV, Miller VM.

J Appl Physiol (1985). 2000 Sep;89(3):1213-23.

30.

Measurement of blood serum cyclosporine levels using capillary "fingerstick" sampling: a validation study.

Pettersen MD, Driscoll DJ, Moyer TP, Dearani JA, McGregor CG.

Transpl Int. 1999;12(6):429-32.

PMID:
10654354
31.

Filter paper lead testing.

Moyer TP, Nixon DN, Ash KO.

Clin Chem. 1999 Dec;45(12):2055-6. No abstract available.

32.

Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects.

Ogburn PL Jr, Hurt RD, Croghan IT, Schroeder DR, Ramin KD, Offord KP, Moyer TP.

Am J Obstet Gynecol. 1999 Sep;181(3):736-43.

PMID:
10486492
33.

Drug monitoring of antiretroviral therapy for HIV-1 infection: method validation and results of a pilot study.

Moyer TP, Temesgen Z, Enger R, Estes L, Charlson J, Oliver L, Wright A.

Clin Chem. 1999 Sep;45(9):1465-76.

34.

Seafood recommendation in Knobeloch paper 'inappropriate'.

Moyer TP.

WMJ. 1999 Jan-Feb;98(1):5. No abstract available.

PMID:
10050146
35.

Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms.

Hurt RD, Offord KP, Croghan IT, Croghan GA, Gomez-Dahl LC, Wolter TD, Dale LC, Moyer TP.

Psychopharmacology (Berl). 1998 Nov;140(1):98-104.

PMID:
9862408
36.

The best diagnostic deal around.

Moyer TP, Hanson CA, Kisabeth RM.

Am J Med. 1998 Jul;105(1):81-3. No abstract available.

PMID:
9688028
37.

Silicon analysis of breast and capsular tissue from patients with saline or silicone gel breast implants: II. Correlation with connective-tissue disease.

Weinzweig J, Schnur PL, McConnell JP, Harris JB, Petty PM, Moyer TP, Nixon D.

Plast Reconstr Surg. 1998 Jun;101(7):1836-41.

PMID:
9623824
38.
39.

Hemosiderosis in cirrhosis: a study of 447 native livers.

Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP.

Gastroenterology. 1997 Mar;112(3):882-8.

PMID:
9041250
40.

Determination of silicon in breast and capsular tissue from patients with breast implants performed by inductively coupled plasma emission spectroscopy. Comparison with tissue histology.

McConnell JP, Moyer TP, Nixon DE, Schnur PL, Salomao DR, Crotty TB, Weinzweig J, Harris JB, Petty PM.

Am J Clin Pathol. 1997 Feb;107(2):236-46.

PMID:
9024074
41.

Silicon analysis of breast and periprosthetic capsular tissue from patients with saline or silicone gel breast implants.

Schnur PL, Weinzweig J, Harris JB, Moyer TP, Petty PM, Nixon D, McConnell JP.

Plast Reconstr Surg. 1996 Oct;98(5):798-803.

PMID:
8823017
42.
43.

The importance of urinary magnesium values in patients with gut failure.

Fleming CR, George L, Stoner GL, Tarrosa VB, Moyer TP.

Mayo Clin Proc. 1996 Jan;71(1):21-4.

PMID:
8538226
44.

Chronic diarrhea: the role of magnesium.

Ho J, Moyer TP, Phillips SF.

Mayo Clin Proc. 1995 Nov;70(11):1091-2. No abstract available.

PMID:
7475340
45.

Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis.

Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V.

Neurology. 1995 Jul;45(7):1340-4.

PMID:
7617195
46.

Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.

Alzaid AA, Dinneen SF, Moyer TP, Rizza RA.

J Clin Endocrinol Metab. 1995 Apr;80(4):1376-81.

PMID:
7714113
47.

Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues.

Bush VJ, Moyer TP, Batts KP, Parisi JE.

Clin Chem. 1995 Feb;41(2):284-94.

48.

The liver biopsy diagnosis of Wilson's disease. Methods in pathology.

Ludwig J, Moyer TP, Rakela J.

Am J Clin Pathol. 1994 Oct;102(4):443-6.

PMID:
7942601
49.

Advances in liver biopsy diagnosis.

Ludwig J, Batts KP, Moyer TP, Poterucha JJ.

Mayo Clin Proc. 1994 Jul;69(7):677-8. Review. No abstract available.

PMID:
8015333
50.

Testing for arsenic.

Moyer TP.

Mayo Clin Proc. 1993 Dec;68(12):1210-1. Review. No abstract available.

PMID:
8246626

Supplemental Content

Loading ...
Support Center